berberine and coenzyme q10

berberine has been researched along with coenzyme q10 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Cacciotti, L; Caminiti, G; Grieco, F; Iaia, L; Marazzi, G; Massaro, R; Pelliccia, F; Rosano, G; Sposato, B; Volterrani, M1
Casiglia, E; D'Avino, M; Lenti, S; Mazza, A; Ramazzina, E; Schiavon, L; Zuin, M1
Chang, RC; Liu, Q; Yang, X1
Andreozzi, S; Dalmaso, S; Fabrizio, A; Marchitto, N; Mauti, M; Raimondi, G; Sindona, F1
Bellentani, S; Cicero, AFG; Colletti, A1
Kandemir, FM; Kilic, K; Kucukler, S; Saglam, YS; Sahin, A; Sakat, MS; Yildirim, S1
Arnás, C; Corbella, E; de Dios, S; Florido, M; Licerán, M; Martin, D; Martinez-Martin, F; Petitbò, D; Pintó, X; Sánchez, A; Sánchez-Hernández, RM; Sarasa, I; Trias, F1
Ameneiros-Lago, E; Fernández-Fernández, FJ; Sardina-Ferreiro, R1

Reviews

1 review(s) available for berberine and coenzyme q10

ArticleYear
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
    Nutrients, 2018, Aug-23, Volume: 10, Issue:9

    Topics: Antioxidants; Berberine; Curcumin; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Observational Studies as Topic; Plant Extracts; Probiotics; Randomized Controlled Trials as Topic; Resveratrol; Salvia miltiorrhiza; Silymarin; Ubiquinone; Vitamin D; Vitamin E; Xanthophylls

2018

Trials

3 trial(s) available for berberine and coenzyme q10

ArticleYear
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
    Advances in therapy, 2011, Volume: 28, Issue:12

    Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Berberine; Biological Products; Blood Glucose; Cholesterol; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Medication Adherence; Prospective Studies; Single-Blind Method; Ubiquinone; Xanthophylls

2011
Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.
    Advances in therapy, 2015, Volume: 32, Issue:7

    Topics: Berberine; Biological Products; Blood Pressure; Cardiovascular Diseases; Diet; Dietary Supplements; Fatty Alcohols; Female; Folic Acid; Health Behavior; Humans; Hypercholesterolemia; Hypertension; Life Style; Lipids; Male; Middle Aged; Risk Factors; Ubiquinone

2015
Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.
    Semergen, 2022, Volume: 48, Issue:6

    Topics: Berberine; Cardiovascular Diseases; Cholesterol, LDL; Dietary Supplements; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Risk Factors; Treatment Outcome; Ubiquinone

2022

Other Studies

4 other study(ies) available for berberine and coenzyme q10

ArticleYear
Editorial: Bioactive Small Molecules in Regulating Inflammation and Metabolic Disorder.
    Current topics in medicinal chemistry, 2016, Volume: 16, Issue:8

    Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Humans; Inflammation; Metabolic Diseases; Selenium; Small Molecule Libraries; Ubiquinone; Vanadium Compounds

2016
Effect of new nutraceutical formulation with policosanol, berberine, red yeast rice, cassia nomame, astaxantine and Q10 coenzyme in patients with low-moderate dyslipidemia associated with intolerance to statins and metabolic syndrome.
    Minerva cardioangiologica, 2018, Volume: 66, Issue:1

    Topics: Berberine; Biological Products; Cassia; Dietary Supplements; Dyslipidemias; Fatty Alcohols; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metabolic Syndrome; Treatment Outcome; Ubiquinone; Xanthophylls

2018
The ameliorative effect of berberine and coenzyme Q10 in an ovalbumin-induced allergic rhinitis model.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018, Volume: 275, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Berberine; Disease Models, Animal; Histamine H1 Antagonists, Non-Sedating; Immunoglobulin E; Interleukin-13; Interleukin-4; Loratadine; Malondialdehyde; Nitric Oxide; Random Allocation; Rats, Sprague-Dawley; Rhinitis, Allergic; Ubiquinone

2018
[Nutraceuticals (monacolin K, berberine and coenzyme Q10) in patients with moderate hypercholesterolemia and low-moderate cardiovascular risk. Potential benefits of combined therapies].
    Semergen, 2023, Volume: 49, Issue:2

    Topics: Berberine; Cardiovascular Diseases; Dietary Supplements; Heart Disease Risk Factors; Humans; Hypercholesterolemia; Lovastatin; Risk Factors

2023